Pharmacokinetics (PK) of Single Doses of Mometasone Furoate (MF) Delivered via the Breezhaler® (BH) and Twisthaler® (TH) Devices in Healthy Subjects

1370366

  • Vaidya, Soniya
  • Khindri, Sanjeev
  • Robinson, Jess
  • Smith, Tom
  • Magnusson, Baldur
  • Kaiser, Guenther
  • Malmqvist, Ulf
  • Patterson, Beverley

  • 1 Translational Sciences, Novartis Institutes for BioMedical Research, Cambridge, MA, USA;

    2 Translational Sciences, Novartis Institutes for BioMedical Research, Horsham, United Kingdom;

    3 Translational Sciences, Novartis Institutes for BioMedical Research, East Hanover, NJ, USA;

    4 Integrated Information Sciences, Novartis Pharma AG, Basel, Switzerland;

    5 Translational Sciences, Novartis Institutes for BioMedical Research, Basel, Switzerland;

    6 Clinical Research and Trial Centre, Skane University Hospital, Lund, Sweden

Clinical Pharmacology in Drug Development 1(4):p 196-197, October 2012.
Copyright © 2012 American College of Clinical Pharmacology
View full text|Download PDF